64 related articles for article (PubMed ID: 5032111)
1. Fibrinolytic enhancement by stanozolol--a two year study.
Davidson JF; McDonald GA; Conkie JA
Br J Haematol; 1972 May; 22(5):639-40. PubMed ID: 5032111
[No Abstract] [Full Text] [Related]
2. Fibrinolytic enhancement by stanozolol: a double blind trial.
Davidson JF; Lochhead M; McDonald GA; McNicol GP
Br J Haematol; 1972 May; 22(5):543-59. PubMed ID: 4555715
[No Abstract] [Full Text] [Related]
3. Fibrinolytic enhancement by stanozolol: a double-blind trial.
Davidson JF; McDonald GA; McNicol GP
J Clin Pathol; 1972 Jul; 25(7):639. PubMed ID: 4560843
[No Abstract] [Full Text] [Related]
4. Treatment of Raynaud's phenomenon by fibrinolytic enhancement.
Jarrett PE; Morland M; Browse NL
Br Med J; 1978 Aug; 2(6136):523-5. PubMed ID: 698554
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic recurrent superficial thrombophlebitis: treatment with fibrinolytic enhancement.
Jarrett PE; Morland M; Browse NL
Br Med J; 1977 Apr; 1(6066):933-4. PubMed ID: 856391
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic enhancement with stanozolol fails to improve symptoms and signs in patients with post-surgical back pain.
Cooper RG; Mitchell WS; Illingworth KJ; Jayson MI
Scand J Rheumatol; 1991; 20(6):414-8. PubMed ID: 1837614
[TBL] [Abstract][Full Text] [Related]
7. [New trends in the treatment of trophic sequelae post-phlebitic syndrome].
Agus GB; Sarcina A; Lorenzi G; Gabrielli L; Tantalo V
Minerva Med; 1981 Oct; 72(42):2805-8. PubMed ID: 7031512
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of fibrinolytic enhancement with stanozolol in the treatment of venous insufficiency.
McMullin GM; Watkin GT; Coleridge Smith PD; Scurr JH
Aust N Z J Surg; 1991 Apr; 61(4):306-9. PubMed ID: 2018441
[TBL] [Abstract][Full Text] [Related]
9. Clinical and laboratory double-blind investigation on effect of fibrinolytic therapy in patients with cutaneous vasculitis.
Dodman B; Cunliffe WJ; Roberts BE; Sibbald R
Br Med J; 1973 Apr; 2(5858):82-4. PubMed ID: 4573315
[TBL] [Abstract][Full Text] [Related]
10. A double-blind trial of intramuscular stanozolol in the prevention of postoperative deep vein thrombosis following elective abdominal surgery.
Blamey SL; McArdle BM; Burns P; Carter DC; Lowe GD; Forbes CD
Thromb Haemost; 1984 Feb; 51(1):71-4. PubMed ID: 6539002
[TBL] [Abstract][Full Text] [Related]
11. The effects of oral stanozolol on fibrinolysis in type 2 diabetes mellitus.
Small M; Lowe GD; MacCuish AC; Forbes CD
Thromb Res; 1986 Oct; 44(2):253-9. PubMed ID: 3787569
[No Abstract] [Full Text] [Related]
12. The effect of fibrinolytic stimulation by stanozolol on postoperative pulmonary complications.
Cuschieri RJ; Morran CG; Lowe GD; Blamey SL; Forbes CD; McArdle CS
Haemostasis; 1985; 15(5):353-6. PubMed ID: 4076841
[TBL] [Abstract][Full Text] [Related]
13. Animal experiments on the enhancement of fibrinolytic potential by anabolic steroids.
Klöcking HP; Markwardt F; Hoffmann A
Biomed Biochim Acta; 1984; 43(4):501-7. PubMed ID: 6548376
[TBL] [Abstract][Full Text] [Related]
14. Stanozolol-induced changes in fibrinolysis and coagulation in healthy adults.
Kluft C; Preston FE; Malia RG; Bertina RM; Wijngaards G; Greaves M; Verheijen JH; Dooijewaard G
Thromb Haemost; 1984 Apr; 51(2):157-64. PubMed ID: 6740547
[TBL] [Abstract][Full Text] [Related]
15. Proceedings: Study of the enhancement of fibrinolysis in an experimental animal.
Gray LJ; Browse NL
Br J Surg; 1974 Apr; 61(4):319-20. PubMed ID: 4832644
[No Abstract] [Full Text] [Related]
16. Metformin and stanozolol in blood fibrinolytic activity.
Menon IS
Br Med J; 1971 Jan; 1(5743):289-90. PubMed ID: 5542166
[No Abstract] [Full Text] [Related]
17. Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol.
Verheijen JH; Rijken DC; Chang GT; Preston FE; Kluft C
Thromb Haemost; 1984 Jul; 51(3):396-7. PubMed ID: 6437007
[TBL] [Abstract][Full Text] [Related]
18. [Activation of the fibrinolytic system with dehydrochlormethyltestosterone].
Hoffmann A; Klöcking HP; Markwardt F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):556-62. PubMed ID: 6083926
[TBL] [Abstract][Full Text] [Related]
19. Treatment of liposclerosis of the leg by fibrinolytic enhancement: a preliminary report.
Browse NL; Jarrett PE; Morland M; Burnand K
Br Med J; 1977 Aug; 2(6084):434-5. PubMed ID: 890326
[TBL] [Abstract][Full Text] [Related]
20. Protein C, an anticoagulant protein, is increased in healthy volunteers and surgical patients after treatment with stanozolol.
Kluft C; Bertina RM; Preston FE; Malia RG; Blamey SL; Lowe GD; Forbes CD
Thromb Res; 1984 Feb; 33(3):297-304. PubMed ID: 6546815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
